stars 1 stars 2 stars 3

EXUMA Biotech is a clinical-stage biotechnology company developing next-generation in vivo cell and gene therapies. Founded in 2015, the company is focused on creating safe, scalable, and accessible therapies that eliminate traditional barriers to CAR-T treatment. Headquartered in West Palm Beach, Florida with operations across the Cayman Islands and Asia, EXUMA takes a globally integrated approach to science and development. Our mission is to create safe, effective, and accessible therapies through platforms designed for high-throughput discovery, tumor-specific targeting, and point-of-care delivery.

EXUMA Biotech Questions

The EXUMA Biotech annual revenue was $4 million in 2026.

Gregory Frost is the Chairman and CEO of EXUMA Biotech.

17 people are employed at EXUMA Biotech.

EXUMA Biotech is based in West Palm Beach, Florida.

The NAICS codes for EXUMA Biotech are [541, 5417, 541711, 54171, 54].

The SIC codes for EXUMA Biotech are [28, 283].

Top EXUMA Biotech Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users